524711 VISTAPH

Vista Pharmaceuticals Share Price

 

 

Start SIP in VISTAPH

Start SIP

Performance

  • Low
  • ₹8
  • High
  • ₹8
  • 52 Week Low
  • ₹7
  • 52 Week High
  • ₹13
  • Open Price₹8
  • Previous Close₹8
  • Volume2,478
  • 50 DMA₹8.25
  • 100 DMA₹8.78
  • 200 DMA₹9.57

Investment Returns

  • Over 1 Month -4.31%
  • Over 3 Month -17.53%
  • Over 6 Month -26.27%
  • Over 1 Year -25.65%

Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!

Invest Now

Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -7.4
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 49
  • P/B Ratio
  • 1.1
  • Average True Range
  • 0.72
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.21
  • RSI
  • 44.24
  • MFI
  • 24.53

Vista Pharmaceuticals Financials

Vista Pharmaceuticals Technicals

EMA & SMA

Current Price
₹8.00
+ 0.44 (5.82%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹7.88
  • 50 Day
  • ₹8.25
  • 100 Day
  • ₹8.78
  • 200 Day
  • ₹9.57

Resistance and Support

7.72 Pivot Speed
  • R3 8.56
  • R2 8.33
  • R1 7.95
  • S1 7.34
  • S2 7.11
  • S3 6.73

Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results (Revised)
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results
2025-05-30 Audited Results
2025-02-19 Preferential Issue of shares & Others Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters.

Vista Pharmaceuticals F&O

Vista Pharmaceuticals Shareholding Pattern

21.19%
0.02%
0%
33.63%
45.16%

About Vista Pharmaceuticals

  • NSE Symbol
  • VISTAPH
  • BSE Symbol
  • 524711
  • Managing Director
  • Mr. Murali Meraga
  • ISIN
  • INE427C01021

Similar Stocks to Vista Pharmaceuticals

Vista Pharmaceuticals FAQs

Vista Pharmaceuticals share price is ₹8 As on 09 February, 2026 | 12:23

The Market Cap of Vista Pharmaceuticals is ₹49.2 Cr As on 09 February, 2026 | 12:23

The P/E ratio of Vista Pharmaceuticals is -7.4 As on 09 February, 2026 | 12:23

The PB ratio of Vista Pharmaceuticals is 1.1 As on 09 February, 2026 | 12:23

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23